CG Oncology (CGON) Other Non-Current Assets (2023 - 2026)

CG Oncology's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• Quarterly Other Non-Current Assets rose 418.6% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 418.6% YoY) and the FY2025 annual result came in at $1.7 million, up 1685.11% from the prior year.
• Other Non-Current Assets was $2.7 million for Q1 2026 at CG Oncology, up from $1.7 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.7 million in Q1 2026 and bottomed at $19000.0 in Q4 2023.
• A 4-year average of $577800.0 and a median of $104000.0 in 2024 frame the typical range for Other Non-Current Assets.
• Peak annual rise in Other Non-Current Assets reached 1685.11% in 2025, while the deepest fall reached 115.09% in 2025.
• CG Oncology's Other Non-Current Assets stood at $19000.0 in 2023, then jumped by 394.74% to $94000.0 in 2024, then jumped by 1685.11% to $1.7 million in 2025, then surged by 59.48% to $2.7 million in 2026.
• Business Quant data shows CGON's Other Non-Current Assets at $2.7 million in Q1 2026, $1.7 million in Q4 2025, and $114000.0 in Q3 2025.